Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. - Wikidata - thesis-toulmin - TriplyDB

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.

http://www.wikidata.org/entity/Q34537191

about

RVX-208, an inducer of ApoA-I in humans, is a BET bromodomain antagonist Pitavastatin in cardiometabolic disease: therapeutic profile Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis Vitamin E therapy results in a reduction in HDL function in individuals with diabetes and the haptoglobin 2-1 genotype Stabilization of high-risk plaques Androgen deprivation therapy and cardiovascular disease: what is the linking mechanism?High density lipoprotein and metabolic disease: Potential benefits of restoring its functional properties Structural Insights into High Density Lipoprotein: Old Models and New Facts High density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular risk Non-clinical development of CER-001 The role of the lymphatic system in cholesterol transport What does procollagen C-endopeptidase enhancer protein 2 have to do with HDL-cholesteryl ester uptake? Or how I learned to stop worrying and love reverse cholesterol transport?Antioxidants, inflammation and cardiovascular disease Mitochondrial function and regulation of macrophage sterol metabolism and inflammatory responses Animal models and the tumor microenvironment: studies of tumor-host symbiosis Lipids and the endothelium: bidirectional interactions Cholesterol efflux pathways regulate myelopoiesis: a potential link to altered macrophage function in atherosclerosis HDL and glucose metabolism: current evidence and therapeutic potential High-density lipoprotein and 4F peptide reduce systemic inflammation by modulating intestinal oxidized lipid metabolism: novel hypotheses and review of literature From evolution to revolution: miRNAs as pharmacological targets for modulating cholesterol efflux and reverse cholesterol transport Cardioprotective functions of HDLs Proteomics investigations of HDL: challenges and promise Niacin, an old drug with a new twist Statins in cardiometabolic disease: what makes pitavastatin different?Molecular mechanisms of cellular cholesterol efflux Treatment of dyslipidemia Mechanisms of Comorbidities Associated With the Metabolic Syndrome: Insights from the JCR:LA-cp Corpulent Rat Strain Diagnosis and treatment of high density lipoprotein deficiency Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic Toxins Nutrition, insulin resistance and dysfunctional adipose tissue determine the different components of metabolic syndrome Will Lipidation of ApoA1 through Interaction with ABCA1 at the Intestinal Level Affect the Protective Functions of HDL?Egg phospholipids and cardiovascular health AIBP: A Novel Molecule at the Interface of Cholesterol Transport, Angiogenesis, and Atherosclerosis Residual Cardiovascular Risk in Chronic Kidney Disease: Role of High-density Lipoprotein High-Density Lipoprotein Processing and Premature Cardiovascular Disease Niacin Therapy, HDL Cholesterol, and Cardiovascular Disease: Is the HDL Hypothesis Defunct?Cholesterol, inflammation and innate immunity Enhanced atheroprotection and lesion remodelling by targeting the foam cell and increasing plasma cholesterol acceptors The cardioprotective protein apolipoprotein A1 promotes potent anti-tumorigenic effects No effect of acute exposure to coarse particulate matter air pollution in a rural location on high-density lipoprotein function

P2860

Q21132391-D5CB1271-0A0B-4D0E-966E-5FE58D487071 Q21246037-7541F050-DB31-4A67-A050-56F206B2FA78 Q24634165-BC720D58-C733-4049-B87B-606608F126CE Q24634553-89863B41-0F41-4CDF-8175-9CA8E716297A Q26738584-D5B80F5F-E87A-4E68-BF9E-3B51A40CE6BB Q26749088-9DAEE912-DC41-4458-9690-94E7423847F8 Q26750603-1F0D0EB9-7A9E-43BF-BF5B-900B4A2DCEC8 Q26770434-840A18C2-DF95-4028-80FF-0D9B0A8F8FC5 Q26775420-479222E6-F8A6-450E-B71E-542AE79FFDCF Q26779282-26D455E1-8B20-4F8B-BD19-9952AF53AEE4 Q26782973-4DCF91DF-78FC-4972-BF2C-12D1C454E6E7 Q26821862-5DE4B928-95DA-479E-8FFD-91FED3D97E67 Q26823009-81E61D6E-A3E6-4C53-A251-0DF3F828E844 Q26825337-484140D4-122F-408D-99DF-4897E6649000 Q26853538-F2238C14-5143-4B0E-AD5F-E9B13D667225 Q26860086-E1B9B02A-64A9-45FA-9F96-F9CA3D7049AE Q26861206-EE1E2C23-7578-4202-97A4-05F01FCA0129 Q26996502-4EA9A9B3-5D7A-4D54-9749-2F293F47B15C Q26996600-83F85498-DA18-400B-903A-BEC394456A9A Q26997647-1820A02C-93CC-4017-9C09-FF3A486E4D87 Q27000421-161B367A-B0D6-4343-B5CE-8A89780127B1 Q27000995-0A7359B9-1B67-449A-9B08-6C8397B14D58 Q27002774-0A508A64-B73F-407A-967E-F8D745BAACCE Q27010638-BFAB7963-7C4D-4CF8-8B7E-64A38C089947 Q27021139-BF6A4CFE-6897-4CEC-8718-27D51C3DBC9A Q27026114-0519AA4E-0D33-4078-A49F-D5BDB90B13A6 Q28066227-7675C5CD-0995-41D3-802F-83C0F836CDB7 Q28067479-0B6A9A81-1CAA-49E3-88BE-998F5EFB860E Q28074264-11CA7D39-A00D-4C86-B082-7C2FE8817033 Q28079661-37AA0F8C-5178-4177-BF14-988E1454B9D2 Q28080768-23D57265-3404-4EE0-BF05-84F7C9D76A70 Q28082796-8C929451-280C-472B-8383-D50EF2F457B1 Q28083058-9F6D7B37-D977-4544-B155-3855101B9759 Q28083619-5BD42078-9420-481C-915F-C2DB6610C620 Q28085143-C9936EAD-C47E-43FB-9E9F-A0F5A8EB9B58 Q28086787-93B36122-2C05-4A1A-ADD7-FE0A626781A6 Q28086912-569BE85A-EE54-4B1C-82C7-D95B6475F01B Q28268889-D7A873C3-64FD-4EAB-8AD6-908724494500 Q28388695-990613F2-E603-4897-BED8-7288E52EF1C5 Q28394963-C44970A7-EE78-4700-86D5-B83F10AA6B29

P2860

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.

http://www.wikidata.org/entity/Q34537191

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.

@ast

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.

@en

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.

@nl

type

label

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.

@ast

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.

@en

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.

@nl

prefLabel

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.

@ast

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.

@en

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.

@nl

P1433

Q34537191-696FB397-7934-4310-BDEA-E4225FBDF02A

P1476

Q34537191-E29AB0FC-8631-4258-9FF5-08D0BA1EB8D0

P2093

Q34537191-2858501F-DE89-485B-B302-38DDF6C50439

Q34537191-3133A8E2-A31C-4277-ACD4-B1088010D5AD

Q34537191-51C3E70A-2355-4BC2-A7F2-AF44906661B9

Q34537191-62659BFE-F726-4637-A1B0-6BEB10CA75BD

Q34537191-90F178E4-3C78-46BF-9535-C3C2C27A5C0D

Q34537191-9916BC3B-1CCD-4192-97D7-61926CAC0E5F

Q34537191-9BF34380-4D1B-4B14-92EA-E0B51E291684

Q34537191-A14F418E-3B49-4AC6-A67F-F9E9078C6CA6

Q34537191-A21E5C35-9FEA-4444-8FC4-2C44D30591BB

Q34537191-BBD19C8D-3F4E-4DF6-8574-797D81D7B59B

P2860

Q34537191-01EFD77B-00D2-4C11-9D8E-C4FB2DDCDEA5

Q34537191-07CE4166-4FE1-49C4-B0A8-E25384C74587

Q34537191-10AB8FA5-C939-49AA-A0E4-52454F7090D6

Q34537191-126A9363-53EC-4CFE-A637-ED9403F021B2

Q34537191-15371105-621A-40A4-9640-B831A2396B11

Q34537191-1F010020-50D4-4223-B6DB-75E47B050CCD

Q34537191-2D09C967-997F-4AA3-BCB6-33B3436E01C3

Q34537191-32C28961-EA68-43DA-A90A-29B16270CD8F

Q34537191-3925CF62-ACAB-43BF-88A2-E3BFD0544998

Q34537191-3EC46EDE-A67D-4C2A-A545-8C7C08EFBB57

P304

Q34537191-53F1DAE1-46FF-4231-A073-D961DA06AC03

P31

Q34537191-CDB3231E-40A8-4324-96A9-24A5179024FC

P356

Q34537191-C2695BA5-E3E3-47E4-86AF-8618D391FE84

P407

Q34537191-8465987F-0540-4562-B074-094BCC2002D7

P433

Q34537191-31C47A22-7C80-434A-97B0-968751210221

P478

Q34537191-B07C3CBE-7280-466C-90D5-39F5984E39FE

P577

Q34537191-AA617FEB-2192-4E35-A3D4-47D2BC184E5E

P698

Q34537191-24EAC845-08F5-4AB0-8944-6EE3B750208B

P921

Q34537191-0D3F78A8-65A1-4568-9101-C9E5E7D3F041

Q34537191-7B0CEEF7-D819-4B1B-95C4-4D8E81133851

P932

Q34537191-6AC4736F-F5CD-43E9-85C4-F5A21E1EF815

P356

P1433

The New England Journal of Medicine

P1476

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.

@en

P2093

Amit V Khera

http://www.w3.org/2001/XMLSchema#string

Amrith Rodrigues

http://www.w3.org/2001/XMLSchema#string

Benjamin C French

http://www.w3.org/2001/XMLSchema#string

Daniel J Rader

http://www.w3.org/2001/XMLSchema#string

Emile R Mohler

http://www.w3.org/2001/XMLSchema#string

George H Rothblat

http://www.w3.org/2001/XMLSchema#string

Julie A Phillips

http://www.w3.org/2001/XMLSchema#string

Kashif Jafri

http://www.w3.org/2001/XMLSchema#string

Margarita de la Llera-Moya

http://www.w3.org/2001/XMLSchema#string

Marina Cuchel

http://www.w3.org/2001/XMLSchema#string

P2860

HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway

A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family

Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants.

Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL

CXCL16 is a marker of inflammation, atherosclerosis, and acute coronary syndromes in humans

Newly identified loci that influence lipid concentrations and risk of coronary artery disease

Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

Effects of torcetrapib in patients at high risk for coronary events

The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages.

P304

127-135

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1001689

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

364

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21226578

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

3030449

http://www.w3.org/2001/XMLSchema#string